Aberrant Methylation in the Fallopian Tubes and Ovarian Cancer Risk

Complete Title: Aberrant Methylation in the Fallopian Tubes and Ovarian Cancer Risk
Trial Phase: N/A
Investigator: Holly Harris

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

N/A
Holly Harris
RG1004952
Aberrant Methylation in the Fallopian Tubes and Ovarian Cancer Risk